ACRS vs EPAM · rev $3.6M vs P/E 14, rev $2.81B
Aclaris Therapeutics Inc (ACRS) versus EPAM Systems Inc (EPAM) — a side-by-side from cached financials, not a winner call.
Aclaris Therapeutics Inc (ACRS) is a biotechnology company listed on NASDAQ.
EPAM Systems Inc (EPAM) is a information technology services company listed on US.
Latest reported ACRS revenue for 2026-06-30 was $3.6M. Net income was -$41.3M. Revenue was up 81.6% from 2026-03-31 to 2026-06-30. ACRS currently screens at market cap $615.9M.
Latest reported EPAM revenue for 2026-06-30 was $2.81B. Net income was $185.5M. EPAM currently screens at market cap $5.10B and trailing P/E 14.0.
ACRS currently screens at market cap $615.9M. EPAM currently screens at market cap $5.10B and trailing P/E 14.0.
Not investment advice. Open the ACRS and EPAM stock pages for the full models.
Not investment advice.